Correlation Between Defence Therapeutics and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Defence Therapeutics and Checkpoint Therapeutics, you can compare the effects of market volatilities on Defence Therapeutics and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Checkpoint Therapeutics.
Diversification Opportunities for Defence Therapeutics and Checkpoint Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Defence and Checkpoint is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Defence Therapeutics and Checkpoint Therapeutics
Assuming the 90 days horizon Defence Therapeutics is expected to under-perform the Checkpoint Therapeutics. In addition to that, Defence Therapeutics is 1.3 times more volatile than Checkpoint Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 460.00 in Checkpoint Therapeutics on September 3, 2024 and sell it today you would lose (29.00) from holding Checkpoint Therapeutics or give up 6.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Defence Therapeutics vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Defence Therapeutics |
| Checkpoint Therapeutics |
Defence Therapeutics and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Defence Therapeutics and Checkpoint Therapeutics
The main advantage of trading using opposite Defence Therapeutics and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Defence Therapeutics vs. Therapeutic Solutions International | Defence Therapeutics vs. Alpha Cognition | Defence Therapeutics vs. Vg Life Sciences | Defence Therapeutics vs. Adagene |
| Checkpoint Therapeutics vs. DiaMedica Therapeutics | Checkpoint Therapeutics vs. Lyra Therapeutics | Checkpoint Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |